Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?

Current Medicinal Chemistry

Volumn 6, Issue 6, 1999, Pages 469-480

  Pacher, Pal ^a   Ungvari, Zoltan ^a   Nanasi, Peter P ^b   Furst, Susanna ^a,c   Kecskemeti, Valeria ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; CALCIUM CHANNEL; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DIBENZEPIN; FLUOXETINE; IMIPRAMINE; LOFEPRAMINE; SEROTONIN UPTAKE INHIBITOR; SODIUM CHANNEL; TRICYCLIC ANTIDEPRESSANT AGENT;

ACTION POTENTIAL; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CLINICAL CHEMISTRY; DEPRESSION; DOG; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ELECTROCARDIOGRAM; GUINEA PIG; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; ORTHOSTATIC HYPOTENSION; PATHOGENESIS; PATIENT MONITORING; RABBIT; TISSUE SPECIFICITY;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CALCIUM CHANNEL BLOCKERS; CITALOPRAM; DOGS; ELECTROPHYSIOLOGY; FLUOXETINE; GUINEA PIGS; HEART; HUMANS; RABBITS; RATS; SEROTONIN UPTAKE INHIBITORS; SODIUM CHANNEL BLOCKERS;

EID: 0033033419     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (202)

1. Kantor, S.J., Bigger, J.T.Jr.; Glassmann, A.H.; et al. J. A. M. A., 1975, 231, 1364-1366.
2. Vohra, J.; Burrows, G.D.; Hunt, D.; et al. Eur. J. Cardiol., 1975, 3, 219-227.
3. Hayes, J.R.; Born, J.F.; Rosenbaum, A.H. Mayo Clin. Proc., 1977, 52, 509-512.
4. Giardina, E.G.; Bigger, J.T.Jr.; Glassmann, A.H. ; Perel, J.M.; Kantor, S.J. Circulation, 1979, 60, 1045-1052.
5. Giardina, E.G.V.; Bigger, J.T.Jr. Am. J. Cardiol., 1982, 50, 172-179.
6. Giardina, E.G.V.; Barnard, T.; Johnson, L.L.; et al. J. Am. Coll. Cardiol., 1986, 7, 1363-1369.
7. Glassmann, A.H.; Bigger, J.T.Jr.; Giardina, E.G.V.; et al. Lancet, 1979, 1, 468-472.
8. Glassmann, A.H.; Johnson, L.L.; Giardina, E.G.V.; et al. J. A. M. A., 1983, 250, 1997-2001.
9. Christensesen, P.; Thomsen, H.Y.; Pedersen, O.L.; et al. Psychopharmacology, 1985, 86, 383-385.
10. Boennert, M.T.; Lovejoy, F.H.Jr. N. Engl. J. Med., 1985, 313, 474-479.
11. Ray, W.A.; Griffin, M.R.; Schaffner, W.; et al. N. Engl. J. Med., 1987, 316, 363-369.
12. Wilens, T.E.; Biederman, J.; Bladessarini, R.J.; Puopolo, P.R.; Flood, J.G. J. Am. Acad. Child Adolesc. Psychiatry, 1993, 32, 798-804.
13. Saraf, K.R.; Klein, D.F.; Gittelman-Klein, R.; Gootman, N.; Greenhill, P. J. Am. Acad. Child Adolesc. Psychiatry, 1978, 60-69.
14. Geller, B.; Farooki, Z.Q.; Cooper, T.B.; Chestnut, E.C.; Abel, A.S. Am. J. Psychiatry, 1985, 142, 1095-97.
15. Schroeder, J.S.; Mullin, A.V.; Elliott, G.R. et al. J. Am. Acad. Child Adolesc. Psychiatry, 1989, 3, 376-79.
16. Biederman, J.; Baldessarini, R.J.; Wright, V.; Knee, D.; Harmatz, J.S.; Goldblatt, A. J. Am. Acad. Child Adolesc. Psychiatry, 1989, 28, 903-11.
17. Biederman, J. J. Am. Acad. Child. Adolesc. Psychiatry, 1991, 30, 495-498.
18. Biederman, J.; Baldessarini, R.J.; Goldblatt, A.; Lapey, K.A.; Doyle, A.; Hesslein, P.S. J. Am. Acad. Child Adolesc. Psychiatry, 1993, 32, 805-813.
19. Bartels, M.G.; Varley, C.K.; Mitchell, J.; Stamm, S.J. J Am. Acad. Child. Adolesc. Psychiatry. 1991, 30, 100-103.
20. Fletcher, S.E.; Case, C.L.; Sallee, F.R.; Hand, L.D. Gillette, P.C. Pediatr., 1993, 122, 652-654.
21. Riddle, M.A.; Geller, B.; Ryan, N. J. Am. Acad. Child Adolesc. Psychiatry, 1993, 32, 792-797.
22. Leonard, H.L.; Meyer, M.C.; Swedo, S.E.; Richter, D.; Hamburger, S.D.; Allen, A.J.; Rapoport, J.L.; Tucker, E. J. Am. Acad. Child Adolesc. Psychiatry, 1995, 34 (11), 1460-1468.
23. Roose, S.P.; Glassmann, A.H.; Giardina, E.G.V.; et al. Arch. Gen. Psychiatry, 1987, 44, 273-275.
24. Roose, S.P.; Glassmann, A.H.; Dalack, G.W. J. Clin. Psychiatry, 1989, 50 (7, suppl), 12-16.
25. Roose, S.P.; Dalack, G.W. J. Clin. Psychiatry, 1992, 53 (9, suppl), 25-31.
26. Glassman, A.H.; Roose, S.P.; and Bigger, J.T.Jr. J. A. M. A., 1993, 269, 2673-2675.
27. Williams, R.B.Jr; Stern, C. Ann. Intern. Med., 1971, 74, 396-398.
28. Crome, P.; Newman, B. J. R. Soc. Med. 1979, 72, 649-653.
29. Callaham, M.; Kassel, D. Ann. Emerg. Med., 1985, 14, 29-37.
30. Hulten, B.A. Pharmacopsychiatry, 1990, 23, 14-16.
31. Rawling, D.; Fozzard, H. J. Pharmacol. Exp. Ther., 1979, 209, 371-375.
32. Tamargo, J.; Rodriguez, S. Experimentia, 1979, 35 (3), 366-7.
33. Tamargo, J.; Rodriguez, S.; and Jalon, P.G. Eur.J. Pharmacol., 1979, 55, 171.
34. Rodriguez, S.; and Tamargo, J. Br. J. Pharmacol., 1980, 70, 15.
35. Weld, F.M.; and Bigger, J.T.Jr. Circ.Res., 1980, 46, 167.
36. Wang, C.M.; Parker, C.H.Jr.; Maxwell, R.A. J. Cardiovasc. Pharmacol., 1981, 3, 101-112.
37. Arlock, P. Acta Pharmacol. Toxicol. Copenh., 1981, 49(4), 248-58.
38. Muir, W.W.; Strauch, S.M.; Schaal, S.F. J Cardiovasc. Pharmacol., 1982, 4(1), 82-90.
39. Nilius, B. Biomed. Biochim., 1984, 43, 1005-1016.
40. Miyakawa, A.; Nishimura, M.; Watanabe, Y. J. Cardiovasc. Pharmacol., 1986, 8 (4), 811-7.
41. Habuchi, Y.; Furukawa, T.; Tanaka, H.; Tsujimura, Y.; Yoshimura, M. J.Pharmacol. Exper.Ther., 1991, 256 (3), 1072-81.
42. Rouet, R.H.; Tisne-Versalles, J.; Adamantidis, M.M.; Vincent, A.; Dupuis, B.A. Fundam. Clin. Pharmacol., 1989, 3 (3), 237-44.
43. Kinugawa, T.; Kotake, H.; Hirai, S.; Miyamoto, J.; Igawa, O.; Hasegawa, J.; Mashiba, H. Eur. J. Pharmacol., 1988, 154, 197-202.
44. Ogata, N.; Narahashi, T. Br. J. Pharmacol., 1989, 97, 905-913.
45. Kinugawa, T.; Kotake, H.; Mashiba, H. Br. J. Pharmacol., 1988, 94, 1250-1256.
46. Igawa, O.; Kotake, H.; Kurata, Y.; Saitho, M.; Fujimoto, Y.; Hasegawa, J.; Mashiba, H. J. Cardiovasc. Pharmacol., 1988, 11 (2), 167-73.
47. Delpon, E.; Tamargo, J.; Sanchez-Chapula, J. N-S. Arch. Pharmacol., 1991, 344, 645-652.
48. Bou-Abboud, E.; Nattel, S. Cardiovasc. Res., 1998, 38 (2), 395-404.
49. Bigger, J.T.Jr, Giardina, E.G.V.; Perel, J.M.; et al. N. Engl. J. Med., 1977, 296, 206-208.
50. Delpón, E.; Valenzua, C.; Tamargo, J. J Cardiovasc. Pharmacol., 1990, 15, 414-420.
51. Valenzuela, C.; Chapula, S.J.; Delpon, E.; Elizalde, A.; Perez, O.; Tamargo, J. Circ. Res., 1994, 74, 687-699.
52. Isenberg, G.; Tamargo, J. Eur. J. Pharmacol., 1985, 108, 121-131.
53. Manzanares, J.; Tamargo, J. Br. J. Pharmacol., 1983, 79, 167-175.
54. Delpon, E.; Tamargo, J.; Sanchez-Chapula, J. Br. J. Pharmacol., 1992, 106, 464-469.
55. Matsuo, S. Jpn. J. Pharmacol., 1967, 17, 279-286.
56. Feighner, J.P.; Cohn, J.B. J. Clin. Psychiatry, 1985, 46 (3, sec 2), 20-25.
57. Feighner, J.P.; Boyer, W.F.; Meredith, C.H.; et al. Br. J. Psychiatry, 1988, 153, 105-108.
58. Altamura, A.C.; Pecundani, M.; Guercetti, G.; et al. Int. Clin. Psychopharmacol., 1989, 4 (suppl 1), 103-106.
59. Montgomery, S.A.; Dufour, H.; Brion, S.; et al. Br. J. Psychiatry, 1988, 153, 69-76.
60. Roos, J.C. Br. J. Clin. Pharmacol., 1983, 15 (suppl 3), 439-445.
61. Wakelin, J.S. Int. Clin. Psychopharmacol., 1986, 7, 221-230.
62. Houillon, P.; Douge, R. Psychol. Med., 1989, 21, 1205-1217.
63. Rahman, M.K.; Akhtar, M.J.; Salva, N.C.; et al. Br. J. Clin. Pharmacol., 1991, 45, 255-258.
64. Phanjoo, A.;Wonnacott, S.; Hodyson, A. Acta Psychiatr. Scand., 1991, 83, 476-479.
65. Lundmark, J.; Scheel, Thomsen, I.; Fjord-Larsen, T.; et al. Acta Psychiatr. Scand., 1989, 80, 76-80.
66. Kuhs, H.; Rudolf, G.A.E. Psychopharmacology, 1990, 702, 379-382.
67. Hutchinson, D.R.; Tong, S.; Moov, C.A.L.; et al. Br. J. Clin. Res., 1991, 2, 43-57.
68. Doogan., D.P.; Caillard, V. J. Clin. Psychiatry, 1988, 49 (8, suppl), 46-51.
69. Doogan., D.P.; Caillard, V. Br. J. Psychiatry, 1992, 160, 217-222.
70. Fisch, C.; Knoebel, S.B. Drugs, 1992, 4, 305-312.
71. Pedersen, O.L.; Kragh-Sorensen, P.; Bjerre, M.; et al. Psychopharmacology, 1982, 77, 199-204.
72. Boeck, V.; Irgensen, A.; Overo, K.F. Psychopharmacology, 1984, 82, 275-281.
73. Overo, K.F. In: Montgomery, S.A., ed. Citalopram: A New Antidepressant from Lundbeck Research. Amsterdam, The Netherlands: Excerta Medica, 1989, 22-30.
74. Rosenberg, C.; Damsbo, N.; Fuglum, E.; Jacobsen, L.V.; & Horsgard, S. Intl. Clin. Psychopharmacology, 1994, 9 (suppl 1), 41-48.
75. Kasper, S.; Fuger, J.; Moller, H.J. Drugs. 1992, 43 (suppl 2), 11-23.
76. Kasper, S. Intl. Clin. Psychopharmacology, 1993, 8, 225-235.
77. Andrews, J.M.; Nemeroff, C.B. Am. J. Med., 1994, 19, 24s-32s.
78. Montgomery, S.A.; Pedersen, V.; Tanghoj, P.; Rasmussen, C.; and Rioux, P. Intl. Clin. Psychopharmacology, 1994, 9 (suppl 1), 35-40.
79. Montgomery, S.A.; Roberts, A.; and Patel A.G. Intl. Clin. Psychopharmacology, 1994, 9 (suppl 1), 49-53.
80. Smallwood, J.K.; Holland, D.R.; Stainberg, M.I. Fed. Proc.; 1985, 44, 1101.
81. Steinberg, M.J.; Smallwood, J.K.; Holland, D.C.; Bymaster, F.P.; Bemis, K.G. Toxicol. Appl. Pharmac., 1986, 82, 70-79.
82. Cooper, G.L. Br. J. Psychiatry, 1988, 153 (suppl 3), 77-86.
83. Upward, J.W.; Edward, J.G.; Goldie, A.; Waller, D.G. Br. J. Clin. Pharmacol., 1988, 26, 399-402.
84. Fisch, C. J. Clin. Psychiatry, 1985, 46 (3, sec 2), 42-44.
85. Enemark, B. Nord. J. Psychiatry, 1993, 47 suppl 30, 57-65.
86. Baker, B.; Dorian, P.; Sandor, P.; Shapiro, C.; Schell, C.; Mitchell, J.; Irvine, M.J. J. Clin. Psychopharmacol., 1997, 17 (1), 15-21.
87. Borys, D.J.; Setzer, S.C.; Ling, L.J.; Reisdorff, J.J.; Day, L.C.; Krenzelok, E.P. J. Toxicol. Clin. Toxicol., 1990, 28, 331-340.
88. Borys, D.J.; Setzer, S.C.; Ling, L.J.; Reisdorf, J.J.; Day, L.C.; Krenzelok, E.P. Am. J. Emerg. Med., 1992, 10 (2), 115-120.
89. Philips, S.; Brent, J.; Kulig, K.; Heiligenstein, J.; Birkett, M. J. Emerg. Med., 1997, 15 (4), 439-445.
90. Edleman, R.J.; Pfeffer, C.R.; Ehler, K.H. J. Am. Acad. Child. Adolesc. Psychiatry, 1994, 33 (4), 591-592.
91. Buff, D.D.; Brenner, R.; Kirtane, S.S.; Gilboa, R. J. Am. Psychiatry, 1991, 52, 174-176.
92. Friedman EH. J. Clin. Psychiatry, 1991, 52(4), 174-176.
93. Friedman, E.H. J. Clin. Psychiatry, 1991, 52, 138-139.
94. Gardner, S.F.; Rutherford, W.F.; Munger, M.A.; Panacek, E.A. Ann. Emerg. Med., 1991, 20, 194-197.
95. Spier, S.A.; Frontera, M.A. J. Clin. Psychiatry, 1991, 52, 377-382.
96. Masquelier, I.; Saint, J.O.; Bourdiol, M.C.; Boiffin, A.; Bouchon, J.P. Presse Med., 1993, 22 (11), 553.
97. Drake WM, Gordon, GD. Lancet 1994, 343(8894), 425-426.
98. Hussein S, Kaufman BM. Postgrad. Med.. J., 1994, 70 (819), 56.
99. Roberge, R.J.; Martin, T.G. Ann. Emerg. Med., 1994, 23 (3), 586-590.
100. Appleby, M.; Mbewu, A.; Clarke, B. Int. J. Cardiol., 1995, 49, 178-180.
101. Graudins, A.; Vossler, C.; Wang, R. Am. J. Emerg. Med., 1997, 15 (5), 501-503.
102. Anderson J, Compton SA. Ulster Med. J., 1997, 66 (2), 144-145.
103. Marchiando, R.J.; Cook, M.D. Ann. Pharmacotherapy. 1995, 29, 937-38.
104. Ravina, T.; Suarez, M.L.; Mendez-Castrillon, J. Int. J. Cardiol., 1998, 65 (3), 311-3.
105. Neely, J.L. W.V. Med. J., 1998, 94 (5), 283-5.
106. Ellison, J.M.; Milofsky, J.E.; Ely, E. J. Clin. Psychiatry, 1990 51, 385-386.
107. Cherin P, Colvez A, Deville de Periere G, Sereni D. J. Clin. Epidemiol., 1997, 50 (3), 313-320.
108. McAnally, L.E.; Threlkeld, K.R.; Dreyling, C.A. Ann. Pharmacother., 1992, 26 (9), 1091-1091.
109. Sternbach, H. J. Clin. Psychopharmacol., 1991, 11, 390-91.
110. Livshits ATL, Danenberg HD. Pharmacopsychiatry, 1997, 30 (6), 274-275.
111. Rich, J.M.; Njo, L.; Roberts, K.W. & Smith, K.P. Anesthesiology, 1998, 88 (2), 529-531.
112. Langlois, R.P.; Paquette, D. Can. J. Psychiatry, 1994, 39 (2), 126-7.
113. Konig, F.; Hafele, M.; Hauger, B.; Loble, M.; Wossner, S.; Wolfersdorf, M. Psychiart. Prax., 1996, 23 (5), 244-5.
114. Erfurth, A.; Loew, M.; Dobmeier, P.; Wendler, G. Nervenarzt., 1998, 69 (7), 629-31.
115. Personne, M.; Persson, H.; Sjoberg, G. Lakartidningen., 1997, 94 (17), 1603-4.
116. Burrows, G.D.; Vohra, J.; Hunt, D.; Sloman, J.G.; Scoggins, B.A. and Davies, B. Br. J. Psychiatry, 1976, 129, 335-341.
117. Burckhardt, D.; Raeder, E.; Muller, V.; et al. J. A. M. A., 1978, 239, 213-216.
118. Glassmann, A.H.; Bigger, J.T.Jr. Arch. Gen. Psychiatry, 1981, 30, 815-820.
119. Cassem, N. J. Clin. Psychiatry, 1982, 43, 22-29.
120. Glassmann, A.H. Annu. Rev. Med, 1984, 35, 503-511.
121. Glassman, A.H.; Roose, S.P.; Giardina, E.G.V.; et al. In Psychopharmacology, Meltzer, H.Y.; Ed.; Raven Press: New York, 1985, 1437-1442.
122. Raeder, E.A.; Burckhardt, D.; Neubauer, H.; et al. Br. Med. J., 1978, 2, 666-667.
123. Stanton, M.S.; Prystowsky, E.N.; Fineberg, N.S.; et al. J. Am. Coll. Cardiol., 1989, 14, 209-215.
124. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N. Engl. J. Med., 1989, 321, 406-412.
125. The Cardiac Arrhythmia Suppression Trial II Investigators. N. Engl. J. Med., 1992, 327, 227-233.
126. Bigger, J.T.Jr. Am. J. Cardiol., 1990, 65, 3D-10D.
127. Popper, C. In Psychiatric Pharmacosciences of Children and Adolescents. American Psychiatria Press: Washington, 1987.
128. Burrows, G.D., McIntyre, I.M.; Judd, F.K.; Norman, T.R. J. Clin. Psychiatry., 1988, 49 (8, suppl), 18-22.
129. Leonard, B.E. Drugs, 1992, 43 (suppl 2), 3-10.
130. Leonard, B.E. J. Clin. Psychiatry, 1993, 54 (8, suppl), 3-15.
131. Hyttel, J. Nord. J. Psychiatry, 1993, 47(suppl 30), 5-12.
132. Hyttel, J. Intl. Clin. Psychopharmacology, 1994, 9 (suppl 1), 19-26.
133. Preskorn, S.H. Clin. Pharmacokinet., 1997, 32 (suppl 1), 1-21.
134. Caccia, S. Clin. Pharmacokinet., 1998, 34 (4), 281-302.
135. Grundemar, L.; Wohlfart, B.; Bengtsson, F.; Eklundh, G. Lancet, 1997, 349, 1602.
136. Barbey, J.T.; Roose, S.P. J.Clin. Psychiatry, 1998, 59 (s15), 42-48.
137. Wong, D.T.; Bymaster, F.P; and Engleman, E.A. Life Sciences, 1995, 57, 5, 411-441.
138. Zarzar, M.N.; Kingsley, R.S. Psychosomatics, 1990, 31, 235-236.
139. Roose, S.P.; Glassman, A.M.; Attia, E.; Woodring, S.; Giardina, E.G.; Bigger, J.T.Jr. Am. J. Psychiatry, 1998, 155(5), 660-5.
140. Glassman, A.M.; Rodriguez, A.I.; Shapiro, P.A. J. Clin. Psychiatry, 1998, 59 (Supp 10), 16-21.
141. Halper, J.P.; Mann, J.J.. Br.J.Psychiatry, 1988, 153 (suppl 3), 87-98.
142. Fuller, R.W., Holland, D.R.; Yen, T.T., Bemkis, K. G.; Stamm, N.B. Life Sci., 1979, 25, 1237-1242.
143. Giles, W.R. & Imaizumi, Y. J.Physiol., 1988, 405, 123-145.
144. Shibata, E.; Drury, T.; Refsum, H.; Aldrete, V.; Giles, W. Am. J. Physiol, 1989, 257, H1773-1781.
145. Escande, D.; Coulombe, A.; Faivre, J.; Deroubaix, E. and Coraboeuf, E. Am. J. Physiol., 1987, 252, H142-H148.
146. Josephson, I.R.; Sanchez-Chapula, J.; Brown, A.M. Circ. Res., 1984, 54, 157-162.
147. Casis, O.; Sanchez-Chapula, J.A. J. Cardiovasc. Pharmacol., 1998, 32 (4), 527-34.
148. Kecskemeti, V.; Pacher, P.; Pankucsi, C.; Nanasi, P. J. Mol. Cell. Biochem., 1996, 160/161, 53-59.
149. Pacher, P.; Kecskemeti, V.; Balogh, I.; Ronai, A.Z.; Szalai, G.; Matkovics, B. J. Mol. Cell. Biochem., 1998, 185, 183-190.
150. Pacher, P.; Kecskemeti, V.; Ungvari, Z.; Korom, S.; Pankucsi, C. N-S. Arch. Pharmacol., 1998, 358 (suppl 2), R641.
151. Pacher, P., Ungvari, Z., Kecskemeti, V.; Furst, S. Curr. Med. Chem. 1998, 5, 381-390.
152. Manzanares, J.; Valenzula, C.; Delgado, C.; and Tamargo, J. Arzheim. Forschg. Drug Res., 1988, 38 (1), 6, 805-809.
153. Khalifa M, Daleau P, Drolet B and Turseon J. J. Mol. Cell. Cardiol. 1998, 30, A136.
154. Orsulak, P.J.; Kenney, J.T.; Debus. J.R.; Crowley, G. and Wittman, P.D. Clin. Chem. 1988, 34, 1875-1878.
155. Kelly MW, Perry PJ, Holstad SG and Garvey MJ. The Drug Monit.,1989, 11, 165-170.
156. Pato, M.T.; Murphy, D.L.; deVane, C.L. J. Clin. Psychopharmacol., 1991, 11, 224-225.
157. Hale, A.S. J. Clin. Psychiatry, 1993, 54 (Suppl 61-70), 71-71.
158. Benfield, P.; Heel, R.C.; Lewis, S.P. Drugs, 1986, 32, 481-508.
159. Lennard, M.S. J. Pharmacol. Exp. Ther., 1990, 67, 273-283.
160. Gram, L.F. Nord. J. Psychiatry, 1993, 47 (suppl 30), 33-39.
161. Crewe, H.K.; Lennard, M.S.; Tucker, G.T.; Woods, F.R.; and Haddock, R.E. Brit. J. Clin. Pharmacol., 1992, 34, 262-265.
162. Brosen, K.; Hansen, J.G.; Nielsen, K.K.; Sindrup, S.H.; and Gram, L.F. Eur., J. Clin. Pharmacol., 1993, 44, 349-355.
163. Nelson, J.C.; Mazure, C.M.; Bowers, M.B.Jr.; and Jatlow, P.I. Arch. Gen. Psychiatry, 1991, 48, 303-307.
164. Preskorn, S.H.; Alderman, J.; Chung, M.; Harrison, W.; Messig, M., and Harris, S. J. Clin. Psychopharmacol., 1994, 14, 90-98.
165. Baumann, P.; Bertschy, G. Nord. J. Psychiatry, 1993, 47 (suppl 30), 13-19.
166. Tollefson, G.D. J. Clin. Psychiatry, 1993, 54 (8, suppl), 48-58.
167. Richelson, E. Mayo. Clin. Proc., 1997, 72 (9), 835-847.
168. Popli, A.P.; Baldessarini, R.J.; Cole, J.O. Arch. Gen. Psychiatry, 1994, 51, 666-667.
169. Karson, C.N., Newton, J.E.O. & Livinston, R., et al. J. Neuropsychiatry Clin. Neurosci.,1993, 5, 322-329.
170. Komoroski, R.A. J. Neuropsychiatry Clin. Neurosci., 1993, 5, 322-329.
171. Komoroski, R.A,; Newton, J.E.; Cardwell, D.; Sprigg, J.; Pearce, J. and Karson, C.N. Magn. Reson. Med., 1994, 31, 204-211.
172. Kornhuber, J.; Retz, W., Riederer, P. J. Neural Transm. Suppl., 1995, 46, 315-23.
173. Marshall, J.; Forker, A. Am. Heart J., 1982, 703, 401-414.
174. Glassman, A.H. & Perel, J.M. Arch. Gen. Psychiat., 1973, 28, 649-653.
175. Jusko, W.J. Drug. Metab. Rev., 1976, 5, 43-140.
176. Elonen, E.; Liniola, M.; Lukkari, I.; Mattila, M.; Acta Pharmacol. Toxicol., 1975, 37, 272-281.
177. Jandhyala, B.; Steenberg, M.; Perel, J.; Manian, A.; Buckley, J. Eur. J. Pharmacol., 1977, 42, 403-410.
178. Nielsen-Kudsk, F.; Quist, S. Acta Pharmacol. et Toxicol., 1980, 46, 263-269.
179. Hennings, E.C.P.; Kiss, J.P.; Vizi, E.S. Brain Res., 1997, 759, 292-294.
180. Colunga, GJ.; Awad, J.N.; Miledi, R. Proc. Natl. Acad. Sci. USA., 1997, 94 (5), 2041-2044.
181. Maggi, L.; Palma, E.; Miledi, R.; Eusebi, F. Mol. Psychiatry, 1998, 3 (4), 350-5.
182. Leonardi, E.T.K.; Azmita, E.C. Neuropsychopharmacology, 1994, 10, 231-238.
183. Holt, A.; Baker, G.B. N-S. Arch. Pharmacol., 1996, 354, 17-24.
184. Murkherjee, J.; Yang, Z.Y. Eur. J. Pharmacol., 1997, 337, 111-114.
185. Stauderman, K.A., Gandhi, V.C., Jones, D.J. Life Sci., 1992, 50 (26), 2125-2138.
186. Lavoie PA, Beauchamp G and Elie R. Can. J. Physiol. Pharmacol., 1997, 75, 983-987.
187. Lavoie, P.A.; Beauchamp, G.; and Elie, R. Can. J. Physiol. Pharmacol., 1990, 68, 1414-1418.
188. Pancrazio, J.J.; Kamatchi, G.L.; Roscoe, A.K.; Lynch, C. J. Pharmacol. Exp. Ther., 1998, 284 (1), 208-214.
189. Tytgat, J.; Maertens, C.; Daenens, P. Br. J. Pharmacol., 1997, 122 (7), 1417-1424.
190. Farrugia G. Gastroenterology, 1996, 110 (5), 1438-45.
191. Velasco, A.; Alamo, C.; Hervas, J.; Carvajal, A. Gen. Pharmacol., 1997, 28 (4), 509-512.
192. Rae, J.L.; Rich, A.; Zamudio, A.C.; Candia, O.A. Am. J. Physiol., 1995, 269 (1Pt1), C250-6.
193. Leander J.D. Epilepsia, 1992, 33 (3), 573-576.
194. Pasini, A.; Tortorella, A. and Gale, K. Brain Research, 1992, 593, 287-290.
195. Pasini A., Tortorella A. and Gale K. Brain Research, 1996, 724, 84-88.
196. Prendiville, S. and Gale, K. Epilepsia, 1993, 34 (2), 381-384.
197. Yan, Q.-S.; Jobe, P.C.; Cheong, J.H.; Ko, K.H.; Dailey, J.W. N-S. Arch. Pharmacol. 1994, 350, 149-152.
198. Wada, Y., Shiraishi, J., Nakamura, M., Hasegawa, H. Psychopharmacology, 1995, 118, 305-309.
199. Favale, E.; Rubino, V.; Mainardi, P.; Lunardi, G.; and Albano, C. Neurology, 1995, 45, 1926-1927.
200. Mogilnicka, E.; Czyrak, A.; Maj, J. Eur. J. Pharmacol., 1987, 138 (3), 413-6.
201. Czyrak, A.; Mogilnicka, E.; Maj, J. Neuropharmacology, 1989, 28 (3), 229-33.
202. Nowak, G. Pol. J. Pharmacol., 1996, 48 (2), 137-43.